• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索慢性阻塞性肺疾病(COPD)导致患者对鸟分枝杆菌复合群(MAC)感染易感性增加的潜在免疫抑制途径。

Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients.

作者信息

Munjal Shafaa, Munjal Shalok, Gao Jingya, Venketaraman Vishwanath

机构信息

Palm Desert High School, Palm Desert, CA 92260, USA.

Department of Psychiatry, State University of New York, Buffalo, NY 14215, USA.

出版信息

Clin Pract. 2021 Sep 9;11(3):619-630. doi: 10.3390/clinpract11030077.

DOI:10.3390/clinpract11030077
PMID:34563006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8482292/
Abstract

Although there has been a drastic decline in the cases of Tuberculosis in the United States, the prevalence of infections caused by Complex (MAC) has steadily increased in the past decades. () is one of the most abundant microorganisms in the MAC species. The mycobacterium genus is divided into two major groups: tuberculosis causing mycobacteria and non-tuberculous mycobacteria. MAC is most prominent among the non-tuberculous mycobacteria. MAC is an opportunistic pathogen that is present in soil, water, and droplets in the air. MAC infections can result in respiratory disease and can disseminate in affected patients. MAC infections are especially prevalent in patients with preexisting respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD). COPD is one of the most common lung conditions in the world with the primary cause being smoking in developed countries. COPD involves chronic inflammation of lung tissue resulting in increased susceptibility to infection. There is a lack of research regarding the pathophysiology that leads COPD patients to be susceptible to MAC infection. Our review paper therefore aims to investigate how the pathogenicity of MAC bacteria and immune decline seen in COPD patients leads to a greater susceptibility to MAC infection among COPD patients.

摘要

尽管美国的结核病病例数已急剧下降,但在过去几十年中,由鸟分枝杆菌复合体(MAC)引起的感染患病率却稳步上升。鸟分枝杆菌是MAC菌群中数量最多的微生物之一。分枝杆菌属分为两大类:引起结核病的分枝杆菌和非结核分枝杆菌。MAC在非结核分枝杆菌中最为突出。MAC是一种机会性病原体,存在于土壤、水和空气中的飞沫中。MAC感染可导致呼吸系统疾病,并可在受影响的患者中传播。MAC感染在患有诸如慢性阻塞性肺疾病(COPD)等现有呼吸系统疾病的患者中尤为普遍。COPD是世界上最常见的肺部疾病之一,在发达国家其主要病因是吸烟。COPD涉及肺组织的慢性炎症,导致易感性增加。关于导致COPD患者易患MAC感染的病理生理学缺乏研究。因此,我们的综述文章旨在研究MAC细菌的致病性以及COPD患者中出现的免疫功能下降如何导致COPD患者更易患MAC感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01f/8482292/d3808618ebd9/clinpract-11-00077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01f/8482292/d3808618ebd9/clinpract-11-00077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01f/8482292/d3808618ebd9/clinpract-11-00077-g001.jpg

相似文献

1
Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients.探索慢性阻塞性肺疾病(COPD)导致患者对鸟分枝杆菌复合群(MAC)感染易感性增加的潜在免疫抑制途径。
Clin Pract. 2021 Sep 9;11(3):619-630. doi: 10.3390/clinpract11030077.
2
[Non-tuberculous mycobacteriosis. What has been coming out].[非结核分枝杆菌病。最新进展]
Kekkaku. 2011 Feb;86(2):113-25.
3
[Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].[日本鸟分枝杆菌复合群感染控制策略:它们如何改善当前状况?]
Kekkaku. 2013 Mar;88(3):355-71.
4
Optimization of In Vitro and Growth Assays for Therapeutic Development.用于治疗开发的体外和生长试验的优化
Microorganisms. 2019 Feb 1;7(2):42. doi: 10.3390/microorganisms7020042.
5
Infection Sources of a Common Non-tuberculous Mycobacterial Pathogen, Complex.常见非结核分枝杆菌病原体复合体的感染源
Front Med (Lausanne). 2017 Mar 7;4:27. doi: 10.3389/fmed.2017.00027. eCollection 2017.
6
Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease.慢性共感染在肺部鸟分枝杆菌复合群疾病中的流行情况和危险因素。
BMJ Open Respir Res. 2014 Aug 28;1(1):e000050. doi: 10.1136/bmjresp-2014-000050. eCollection 2014.
7
Comparative Genomics of Mycobacterium avium Complex Reveals Signatures of Environment-Specific Adaptation and Community Acquisition.鸟分枝杆菌复合群的比较基因组学揭示了环境特异性适应和群落获得的特征。
mSystems. 2021 Oct 26;6(5):e0119421. doi: 10.1128/mSystems.01194-21. Epub 2021 Oct 19.
8
Zoonotic aspects of Mycobacterium bovis and Mycobacterium avium-intracellulare complex (MAC).牛分枝杆菌与鸟分枝杆菌-胞内分枝杆菌复合体(MAC)的人畜共患病方面。
Vet Res. 2005 May-Jun;36(3):411-36. doi: 10.1051/vetres:2005001.
9
Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.非结核分枝杆菌肺病由鸟分枝杆菌复合群和脓肿分枝杆菌复合群混合感染引起。
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.01105-18. Print 2018 Oct.
10
Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.鸟分枝杆菌复合群肺病:HIV 阴性患者的治疗选择
J La State Med Soc. 2008 Sep-Oct;160(5):248-54; quiz 254, 293.

引用本文的文献

1
Cost-effectiveness of home care compared to hospital care in patients with chronic obstructive pulmonary disease (COPD): a systematic review.慢性阻塞性肺疾病(COPD)患者家庭护理与医院护理的成本效益:一项系统评价
Front Med (Lausanne). 2024 Oct 3;11:1405840. doi: 10.3389/fmed.2024.1405840. eCollection 2024.
2
Additive Effects of Cyclic Peptide [R4W4] When Added Alongside Azithromycin and Rifampicin against Infection.环肽[R4W4]与阿奇霉素和利福平联合使用时对感染的附加作用。
Pathogens. 2023 Aug 18;12(8):1057. doi: 10.3390/pathogens12081057.
3
[New therapeutic advances in patients with lung cancer immunosuppressed with chronic lung diseases in the period 2014-2022 from the review of the literature.].

本文引用的文献

1
Treatment Dilemmas in Disseminated Nontuberculous Mycobacterial Infections With Interferon-gamma Autoantibodies.伴有γ-干扰素自身抗体的播散性非结核分枝杆菌感染的治疗困境
Open Forum Infect Dis. 2021 Jun 23;8(7):ofab253. doi: 10.1093/ofid/ofab253. eCollection 2021 Jul.
2
Disseminated and infection causing an immune reconstitution inflammatory syndrome in a female patient with HIV infection.HIV 感染女性患者出现播散性感染并引发免疫重建炎症综合征。
BMJ Case Rep. 2021 May 28;14(5):e241037. doi: 10.1136/bcr-2020-241037.
3
Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.
[基于文献综述的2014 - 2022年期间慢性肺病免疫抑制肺癌患者的新治疗进展。]
Rev Esp Salud Publica. 2023 Apr 14;97:e202302015.
4
Nontuberculous Mycobacteria as Sapronoses: A Review.非结核分枝杆菌作为腐物寄生菌病:综述
Microorganisms. 2022 Jul 3;10(7):1345. doi: 10.3390/microorganisms10071345.
5
Protective Efficacy of BCG Vaccine against and Non-Tuberculous Mycobacterial Infections.卡介苗对结核分枝杆菌和非结核分枝杆菌感染的保护效力
Vaccines (Basel). 2022 Mar 3;10(3):390. doi: 10.3390/vaccines10030390.
非结核分枝杆菌病的诊断与治疗方法
J Clin Tuberc Other Mycobact Dis. 2021 May 8;24:100244. doi: 10.1016/j.jctube.2021.100244. eCollection 2021 Aug.
4
Patients with non-tuberculous mycobacteria in respiratory samples: a 5-year epidemiological study.呼吸道标本中非结核分枝杆菌感染患者:一项 5 年的流行病学研究。
Rev Esp Quimioter. 2021 Apr;34(2):120-125. doi: 10.37201/req/121.2020. Epub 2021 Feb 1.
5
Immune defects in patients with pulmonary disease without cystic fibrosis.无囊性纤维化的肺部疾病患者的免疫缺陷
ERJ Open Res. 2020 Nov 10;6(4). doi: 10.1183/23120541.00590-2020. eCollection 2020 Oct.
6
Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases.肺部微生物群在与慢性肺部疾病相关的固有免疫反应中的作用。
Front Med (Lausanne). 2020 Sep 18;7:554. doi: 10.3389/fmed.2020.00554. eCollection 2020.
7
Is the Leicester Cough Questionnaire useful for nontuberculous mycobacterial lung disease?莱斯特咳嗽问卷对于非结核分枝杆菌肺病是否有用?
Respir Investig. 2021 Jan;59(1):120-125. doi: 10.1016/j.resinv.2020.06.005. Epub 2020 Aug 14.
8
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.非结核分枝杆菌肺病治疗:美国胸科学会/欧洲呼吸学会/欧洲临床微生物学和传染病学会/美国感染病学会临床实践指南。
Clin Infect Dis. 2020 Aug 14;71(4):905-913. doi: 10.1093/cid/ciaa1125.
9
Transient Decrease of Circulating and Tissular Dendritic Cells in Patients With Mycobacterial Disease and With Partial Dominant IFNγR1 Deficiency.分枝杆菌病患者和部分显性 IFNγR1 缺陷患者的循环和组织树突状细胞短暂减少。
Front Immunol. 2020 Jun 26;11:1161. doi: 10.3389/fimmu.2020.01161. eCollection 2020.
10
Risk factors for nontuberculous mycobacterial isolation in patients with cystic fibrosis: A meta-analysis.囊性纤维化患者中非结核分枝杆菌分离的危险因素:一项荟萃分析。
Pediatr Pulmonol. 2020 Oct;55(10):2653-2661. doi: 10.1002/ppul.24913. Epub 2020 Jul 23.